CONTINUOUS SUBCUTANEOUS INSULIN INFUSION THERAPY: VARIATION OF THE BASAL INSULIN LINE

被引：0
|
作者：
Belo, S. [1 ,2 ]
Esteves, C. [1 ,2 ]
Neves, C. [1 ,2 ]
Carvalho, D. [1 ,2 ]
机构：
[1] Ctr Hosp Sao Joa, Oporto, Portugal
[2] Univ Porto, Fac Med, P-4100 Oporto, Portugal
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2013年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A34 / A35
页数：2
相关论文
共 50 条
  • [41] PHARMACOKINETICS OF CONTINUOUS SUBCUTANEOUS INSULIN INFUSION
    LAURITZEN, T
    PRAMMING, S
    DECKERT, T
    BINDER, C
    DIABETOLOGIA, 1983, 24 (05) : 326 - 329
  • [42] INSULIN ADMINISTRATION BY CONTINUOUS SUBCUTANEOUS INFUSION
    PICKUP, JC
    KEEN, H
    PARSONS, JA
    ALBERTI, KGGM
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1978, 54 (02): : P21 - P21
  • [43] USE OF AN INFUSION SET IN CONTINUOUS SUBCUTANEOUS INSULIN INFUSION (CSII) THERAPY USING A PERSONAL INSULIN PUMP
    Szewczyk, Alicja
    Tobiasz-Kalkun, Natasza
    Stefanowicz-Bielska, Anna
    Kobos, Ewa
    Mlynarczuk, Miroslawa
    Kapusciok, Justyna
    Michalowska, Jolanta
    PIELEGNIARSTWO XXI WIEKU-NURSING IN THE 21 CENTURY, 2020, 19 (03): : 195 - 197
  • [44] INSULIN DOSE REDUCTION WITH THE TRANSITION FROM CONVENTIONAL TO CONTINUOUS SUBCUTANEOUS INFUSION INSULIN THERAPY
    Belo, S.
    Esteves, C.
    Neves, C.
    Carvalho, D.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A34 - A34
  • [45] SUBCUTANEOUS USE OF REGULAR HUMAN INSULIN (NOVO) - PHARMACOKINETICS AND CONTINUOUS INSULIN INFUSION THERAPY
    SONNENBERG, GE
    KEMMER, FW
    CUPPERS, HJ
    BERGER, M
    DIABETES CARE, 1983, 6 : 35 - 39
  • [46] FEATURES OF THE BASAL INSULIN-RATE, ON CONTINUOUS SUBCUTANEOUS INSULIN INFUSION, IN PATIENTS WITH OPTIMAL GLYCEMIC CONTROL
    Tasende, C.
    Botella, M.
    Rubio, J. A.
    Pelaez, N.
    Trifu, D.
    Gomez-Montes, M. P.
    Alvarez, J.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2013, 15 : A52 - A52
  • [47] Lower dose basal insulin infusion has positive effect on glycaemic control for children with type I diabetes on continuous subcutaneous insulin infusion therapy
    Schulten, Ron J.
    Piet, Jessica
    Bruijning, Patricia C. J. L.
    de Waal, Wouter J.
    PEDIATRIC DIABETES, 2017, 18 (01) : 45 - 50
  • [48] Basal insulin: Continuous glucose monitoring reveals less overnight hypoglycemia with continuous subcutaneous insulin infusion than with glargine
    Armstrong, DU
    King, AB
    DIABETES, 2002, 51 : A92 - A92
  • [49] Type 1 diabetes patients can temporarily switch from continuous subcutaneous insulin infusion with insulin aspart to basal bolus therapy with insulin aspart and insulin glargine
    Bode, B
    Hirsch, I
    Hu, P
    Santiago, O
    DIABETES, 2003, 52 : A102 - A102
  • [50] Treating insulin allergy with continuous subcutaneous insulin infusion (CSII)
    Kerr, D.
    Richardson, T.
    DIABETIC MEDICINE, 2006, 23 (10) : 1159 - 1159
12345